According to a report from Reuters on October 16th, British American Tobacco (BAT) will be launching a nicotine pouch product called Velo Plus in the United States, which uses synthetic nicotine.
The CEO of BAT's US subsidiary Reynolds Tobacco (Reynolds American), David Waterfield, revealed that this new product is expected to be launched in 2025, offering multiple nicotine strengths and containing synthetic nicotine. The launch of Velo Plus marks the first time a major tobacco company has explicitly used synthetic nicotine.
Traditionally, large tobacco companies including BAT produce smoking alternatives such as e-cigarettes, which typically contain nicotine extracted from tobacco plants. Synthetic nicotine, on the other hand, is produced in a laboratory using chemical methods. According to David, from a chemical perspective, natural nicotine and synthetic nicotine are the same. In the future, BAT will explore other opportunities in the synthetic nicotine field.
In recent years, synthetic nicotine has been more widely used in the United States in order to circumvent the lengthy application process of the FDA. Previously, the FDA only had regulatory authority over natural nicotine, so small e-cigarette or nicotine pouch manufacturers did not need to follow the FDA's application process. This law was amended in April 2022.
David also mentioned that Velo Plus is a product acquired by BAT, with its previous owner submitting an FDA application before the deadline in May 2022. This means that the product can continue to be sold during the approval process.
BAT estimates that the revenue of the American e-cigarette market will increase from approximately 9 billion pounds currently to 14 billion pounds by 2030, while the revenue of the nicotine pouch industry will increase from 1.7 billion pounds to 7 billion pounds during the same period.
David stated that the current 9% decline in combustible tobacco revenue in the United States is "abnormal," and he expects that the industry's revenue growth will stabilize at around 1% in the American market over the next ten years.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
